Literature DB >> 7880199

Polymyositis, pulmonary fibrosis, and hepatitis C.

D Weidensaul1, T Imam, M M Holyst, P D King, R W McMurray.   

Abstract

Polymyositis has been associated with several viral infections, and a spectrum of immune-related diseases may occur with hepatitis C virus (HCV) infection. Both polymyositis and HCV infection may be accompanied by interstitial lung disease; however, no association between polymyositis and HCV infection has been reported previously. We report a new association in a patient with HCV infection: anti-Jo-1 positive polymyositis and interstitial lung disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7880199     DOI: 10.1002/art.1780380324

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  6 in total

1.  Hepatocellular carcinoma,polymyositis,rhabdomyolysis,and acute renal failure.

Authors:  Mi-Jeong Kim; Jin-A Kim; Mi-Sook Sung; Jun-Ki Min
Journal:  J Korean Med Sci       Date:  2004-12       Impact factor: 2.153

2.  Values of high-resolution computed tomography and pulmonary function tests in managements of patients with chronic hepatitis C virus infection.

Authors:  Oguzhan Okutan; Zafer Kartaloglu; Ahmet Ilvan; Ali Kutlu; Erkan Bozkanat; Emir Silit
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

3.  Hepatitis C and pulmonary fibrosis: Hepatitis C and pulmonary fibrosis.

Authors:  Rasoul Aliannejad; Mostafa Ghanei
Journal:  Hepat Mon       Date:  2011-02       Impact factor: 0.660

Review 4.  The lung as a possible target for the immune reaction in myositis.

Authors:  Sonye K Danoff; Livia Casciola-Rosen
Journal:  Arthritis Res Ther       Date:  2011-07-13       Impact factor: 5.156

Review 5.  Syphilitic myositis: a case-based review.

Authors:  Elaine Yacyshyn; Praveena Chiowchanwisawakit; Derek J Emery; Jack Jhamandas; Lothar Resch; Geoffrey Taylor
Journal:  Clin Rheumatol       Date:  2011-01-07       Impact factor: 3.650

Review 6.  Genetics and autoantibodies.

Authors:  Carlo Perricone; Nancy Agmon-Levin; Fulvia Ceccarelli; Guido Valesini; Juan-Manuel Anaya; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2013-07       Impact factor: 4.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.